Skip to footer

business

U.S. to See Higher Generic Drug Prices Thanks to Tariffs, CEO Warns

Updated 1 min read

Published by Agyata NewsroomEditorial policyCorrections

Archived — last updated

The CEO of a leading Indian pharma firm has warned that the U.S. will see higher generic drug prices due to tariffs imposed on Indian pharmaceuticals.

Latest updates

U.S. to See Higher Generic Drug Prices Thanks to Tariffs, CEO Warns

The CEO of a leading Indian pharma firm has warned that the U.S. will see higher generic drug prices due to tariffs imposed on Indian pharmaceuticals. The tariffs have made it difficult for Indian companies to export their products to the U.S., leading to a shortage of generic drugs. The CEO has urged the U.S. government to reconsider the tariffs, which he believes will have a negative impact on public health. The development of this situation is a concern for the global pharmaceutical industry and could have far-reaching consequences.

CNBC

U.S. to See Higher Generic Drug Prices Thanks to Tariffs, CEO of Leading India Pharma Firm Warns

The CEO of a leading India pharma firm has warned that the U.S. will see higher generic drug prices due to tariffs imposed by the U.S. government. The tariffs are expected to increase the cost of generic drugs in the U.S. market, making them less affordable for consumers. The pharma firm has expressed concerns over the impact of the tariffs on the U.S. healthcare system. The U.S. government has imposed tariffs on several Indian pharma products, citing national security concerns.

CNBC

Sources

AI-assisted summary of the reporting above. Quotes are kept to one sentence. Copyright concern? See our DMCA takedown page.

Topics